Angiocentric T-cell and NK/T-cell lymphomas: Radiotherapeutic viewpoints

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 4, 2004, Pages 1127-1137

  Koom, Woong Sub ^a   Chung, Eun Ji ^c   Yang, Woo Ick ^b   Shim, Su Jung ^a   Suh, Chang Ok ^a   Roh, Jae Kyung ^b   Yoon, Joo Heon ^b   Kim, Gwi Eon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c National Health Insurance Corporation   (South Korea)

Author keywords

Angiocentric lymphoma; Dose response relationship; Local tumor control; NK T cell lymphoma

Indexed keywords

CHEMOTHERAPY; PATIENT TREATMENT; RADIOTHERAPY; RISK ASSESSMENT; TUMORS;

LYMPHOMAS; NATURAL KILLERS;

ONCOLOGY;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DATA ANALYSIS; DOSE CALCULATION; DOSE RESPONSE; FEMALE; HUMAN; INFORMATION RETRIEVAL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NATURAL KILLER CELL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION RESPONSE; RADIOSENSITIZATION; RISK FACTOR; SALVAGE THERAPY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; T CELL LYMPHOMA; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; RECURRENCE; REGRESSION ANALYSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 3042513353     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.12.006     Document Type: Article

References (41)

1. Eichel B.S., Harrison E.G., Devine D.K., et al. Primary lymphoma of the nose including a relationship to lethal midline granuloma. Am J Surg. 112:1966;597-605
2. McDonald T.J., DeRemee R.A., Harrison E.G. The protean clinical features of polymorphic reticulosis (lethal midline granuloma). Laryngoscope. 86:1976;936-945
3. Kassel S.H., Echevarria R.A., Guzzo F.P. Midline malignant reticulosis (so-called lethal midline granuloma). Cancer. 23:1968;920-935
4. Fechner R.E., Lampin D.W. Midline malignant reticulosis. Arch Otolaryngol. 95:1972;467-476
5. Jaffe E.S. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest. 2:1984;413-426
6. Lipford E.H., Margolick J.B., Longo D.L., et al. Angioimmunoproliferative lesion A clinicopathologic spectrum of post-thymic T-cell proliferation. Blood. 72:1988;1674-1681
7. Medeiros L.J., Peiper S.C., Elwood L., et al. Angiocentric immunoproliferative lesions A molecular analysis of eight cases. Hum Pathol. 22:1991;1150-1157
8. Fellbaum C., Hansmann M.L., Lennert K. Malignant lymphomas of the nasal cavity and paranasal sinuses. Virchow Arch A. 414:1989;399-405
9. Ho F.C.S., Choy D., Loke S.L., et al. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract A clinicopathologic study of 70 cases and immunophenotypic studies of 16 cases. Hum Pathol. 21:1990;1041-1050
10. Ferry J.A., Sklar J., Zukerberg L.R., et al. Nasal lymphoma - A clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol. 15:1991;268-279
11. Aviles A., Rodriguez L., Guzman R., et al. Angiocentric T-cell lymphoma of the nose, paranasal sinus and hard palate. Hematol Oncol. 10:1992;141-147
12. Sorbrevilla-Calvo P., Meneses A., Alfaro P. Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma (polymorphic reticulosis). Acta Oncol. 32:1993;69-72
13. Liang R., Todd D., Chan T.K., et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol. 13:1995;666-670
14. Jaffe E.S., Chan J.K.C., Su I.J., et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas Definitions, differential diagnosis and epidemiology. Am J Surg Pathol. 20:1996;103-111
15. Kim G.E., Cho J.H., Yang W.I., et al. Angiocentric lymphoma of the head and neck Patterns of systemic failure after radiation treatment. J Clin Oncol. 18:2000;54-63
16. Ko Y.H., Kim C.W., Park C.S., et al. REAL classification of malignant lymphomas in the Republic of Korea. Cancer. 83:1998;806-812
17. Halperin E.C., Dosoretz D.E., Goodman M. Radiotherapy of polymorphic reticulosis. Br J Radiol. 55:1982;645-649
18. Grange C., Cabane J., Dubois A., et al. Centrofacial malignant granuloma. Medicine. 71:1992;179-196
19. Chan J.K.C., Ng C.S., Lau W.H., et al. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol. 11:1987;418-429
20. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms A proposal from the International Lymphoma Study Group. Blood. 84:1994;1361-1392
21. Kanavaros P., Leses M.C., Briere J., et al. Nasal T-cell lymphoma - A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood. 81:1993;2688-2695
22. Chiang A.K., Srivastava G., Lau P.W., et al. Differences in T-cell receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types Implications on cellular origin. Hum Pathol. 27:1996;701-707
23. Mori N., Yatabe Y., Oka K., et al. Expression of perforin in nasal lymphoma Additional evidence of its natural killer cell derivation. Am J Pathol. 149:1996;699-705
24. Jaffe E.S., Krenacs L., Kumar S., et al. Extranodal peripheral T-cell and NK-cell neoplasms. Am J Clin Pathol. 111:(Suppl. 1):1999;46-55
25. Harris N.L., Jaffe E.S., Diebold J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues Report of the clinical advisory committee meeting - Airlie house, Virginia, November 1997. J Clin Oncol. 17:1999;3835-3849
26. Fauci A.S., Johnson R.E., Wolf S.M. Radiation therapy of midline granuloma. Ann Int Med. 84:1976;140-147
27. Smalley S.R., Cupps R.E., Anderson J.A., et al. Polymorphic reticulosis limited to the upper aerodigestive tract - Natural history and radiotherapeutic considerations. Int J Radiat Oncol Biol Phys. 15:1988;599-605
28. Chen H.H.W., Fong L., Su I.J., et al. Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma A retrospective analysis covering a 34-year period. Radiother Oncol. 38:1996;1-6
29. Itami J., Itami M., Mikata A., et al. Non-Hodgkin's lymphoma confined to the nasal cavity Its relationship to the polymorphic reticulosis and results of radiation therapy. Int J Radiat Oncol Biol Phys. 20:1991;797-802
30. Kern W.F., Spier C.M., Hanneman E.H., et al. Neural cell adhesion molecule-positive peripheral T-cell lymphoma A rare variant with a propensity for unusual sites of involvement. Blood. 79:1992;2432-2437
31. van Grop J., de Bruin P.C., Sie-Go D.M.D.S., et al. Nasal T-cell lymphoma A clinicopathological and immunophenotypic analysis of 13 cases. Histopathology. 27:1995;139-148
32. Ramsay A.D., Rooney N. Lymphomas of the head and neck 1 Nasofacial T-cell lymphomas. Oral Oncol Eur J Cancer. 29B:1993;99-102
33. Logsdon M.D., Ha C.S., Kavadi V.S., et al. Lymphoma of the nasal cavity and paranasal sinuses Improved outcome and altered prognostic factors with combined modality therapy. Cancer. 80:1997;477-488
34. Kim G.E., Lee S.W., Chang S.K., et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol. 61:2001;261-269
35. Kim W.S., Song S.Y., Ahn Y.C., et al. CHOP followed by involved field radiation Is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol. 12:2001;349-352
36. Cheung M.M.C., Chan J.K.C., Lau W.H., et al. Early stage nasal NK/T-cell lymphoma Clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys. 54:2002;182-190
37. Shikama N., Izuno I., Oguchi M., et al. Clinical stage IE primary lymphoma of the nasal cavity Radiation therapy and chemotherapy. Radiology. 204:1997;467-470
38. Kwong Y.L., Chan A.C.L., Liang R., et al. CD56+ NK lymphomas Clinicopathological features and prognosis. Br J Hematol. 97:1997;821-829
39. Li Y.X., Coucke P.A., Li J.Y., et al. Primary non-Hodgkin's lymphoma of the nasal cavity Prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer. 83:1998;449-456
40. Ribrag V., Ell Hajj M., Janot F., et al. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia. 15:2001;1123-1126
41. Sakata K., Hareyama M., Ohuchi A., et al. Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncol. 36:1997;307-311